Isoquinolines And Beta-Carbolines As Neurotoxins And Neuroprotectants
Kurzinformation
inkl. MwSt. Versandinformationen
Artikel zZt. nicht lieferbar
Artikel zZt. nicht lieferbar

Beschreibung
The specific topic, "Isoquinolines And Beta-Carbolines As Neurotoxins And Neuroprotectants - New Perspectives In Parkinson`S Disease Therapy," was chosen in light of accumulating neurobiological evidence indicating that, in addition to exogenous neurotoxins (e.g., 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine [MPTP]), endogenous compounds may play an important role in the most common neurodegenerative disorders (e.g., Parkinson`s disease). Two groups of amine related compounds, which appeared chemically like MPTP, were detected in human brain and cerebrospinal fluid (CSF): ß-carbolines (BCs) and tetrahydroisoquinolines (TIQs). These are heterocyclic compounds formed endogenously from phenylalanine/tyrosine (TIQs) and tryptophan, tryptamine, and 5-hydroxytryptamine (BCs), respectively and exert a wide spectrum of psychopharmacological and behavioral effects. The TIQs and BCs may bind to their own high affinity sites on neuronal membranes associated with or located close to the receptors of neurotransmitters. Research on TIQs and BCs is stimulated also by their possible role in pathological conditions, especially parkinsonism and alcoholism. Recently, clinical interest has been spurred by their role as neuroprotective, and even neurorestorative, anticonvulsant and antiaddictive, substances. In this book we are going to summarize, for the first time, the results from behavioral, neurochemical and molecular experiments, which demonstrate a wide spectrum of TIQs and BCs effects - from their rather mild neurotoxic actions to the important neuroprotective and antiaddictive properties. Additionally, the recent results of experimental studies in vivo have allowed a much better understanding and simultaneous comparison of the neurochemical and molecular mechanisms underlying the neuroprotective and neurotoxic actions of endogenous TIQs and BCs and have pointed to the possibility of their therapeutic applications in neurodegenerative diseases such as Parkinson's disease. von Antkiewicz-Michaluk, Lucyna und Rommelspacher, Hans
Produktdetails
So garantieren wir Dir zu jeder Zeit Premiumqualität.
Über den Autor
- paperback
- 160 Seiten
- Erschienen 1980
- Springer Berlin Heidelberg
- Gebunden
- 432 Seiten
- Erschienen 2011
- Springer
- hardcover
- 279 Seiten
- Erschienen 2015
- Springer
- Kartoniert
- 396 Seiten
- Erschienen 1971
- Springer
- paperback
- 736 Seiten
- Erschienen 2003
- Oxford University Press, U....
- paperback
- 148 Seiten
- Erschienen 1991
- Springer
- Gebunden
- 736 Seiten
- Erschienen 2013
- Springer Spektrum
- Gebunden
- 501 Seiten
- Erschienen 2021
- Springer
- Gebunden
- 248 Seiten
- Erschienen 2022
- Urban & Fischer Verlag/Else...
- paperback
- 848 Seiten
- Erschienen 2009
- Thieme
- paperback
- 288 Seiten
- Erschienen 2023
- Urban & Fischer Verlag/Else...
- Gebunden
- 304 Seiten
- Erschienen 2020
- Thieme
- Kartoniert
- 304 Seiten
- Erschienen 1985
- Springer
- Gebunden
- 196 Seiten
- Erschienen 2013
- Springer
- hardcover -
- Erschienen 1996
- Thieme, Stuttgart




